Why the study?
Do propranolol and RO3-4787 reduce blood pressure compared to placebo in patients with arterial hypertension?
Do propranolol and RO3-4787 reduce blood pressure compared to placebo in patients with arterial hypertension?
Propranolol and RO3-4787 similarly reduce blood pressure in hypertensive patients, though propranolol causes a greater reduction in heart rate.
Answers are grounded in this paper and cite their sources.
RO3-4787 matches propranolol's blood pressure reduction with less heart rate slowing; confirms distinct hemodynamic effects for further evaluation in hypertension.
The effects of propranolol and RO3-4787, a new beta-adrenoceptor antagonist with a partial agonist activity, have been studied in a blind, cross-over comparison with placebo. 2. In ten patients who completed the study, the two drugs produced a similar reduction in blood pressure; the reduction in heart rate with propranolol was significantly (P less than 0.001) greater than that produced by RO3-4787. 3. Plasma renin activity averaged 4.13 +/- 1.37 ng h-1 ml-1 on placebo, fell to 3.64 +/- 1.47 ng h-1 ml-1 on propranolol and to 2.50 +/- 1.39 ng h-1 ml-1 on RO3-4787. 4. No correlation was demonstrable between the log plasma concentration of either propranolol or RO3-4787 and change in blood pressure.
No takes yet. Share an insight, caveat, or question.
George et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: